BDMD
Baird Medical Investment Holdings LimitedNASDAQHealthcare$1.95-2.56%ClosedMarket Cap: $71.6M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
7.64
PEG
—
P/B
1.41
P/S
2.19
EV/EBITDA
80.48
DCF Value
$27.16
FCF Yield
-11.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
86.9%
Operating Margin
-0.7%
Net Margin
-10.0%
ROE
-8.4%
ROA
-4.1%
ROIC
-0.4%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2025 | $8.0M | $-11.3M | $-0.43 |
| Q4 2024 | $23.9M | $8.1M | $0.38 |
| FY 2024 | $37.0M | $12.5M | $0.49 |
| Q2 2024 | $13.1M | $4.3M | $-0.32 |
Trading Activity
Insider Trades
View AllRagan Joseph Douglas IIIdirector
SellTue Mar 31
Hou Weidirector
SellTue Mar 31
WU HAIMEIdirector, 10 percent owner:
SellFri Mar 27
Company Info
Sector
Healthcare
Industry
—
Country
CN
Exchange
NASDAQ
Beta
-1.16
Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.